deltatrials
Not Yet Recruiting NA INTERVENTIONAL 1-arm NCT06794424

Impact of Ziwig Endotest® on the Management of Patients with Clinical Symptoms of Endometriosis Inconsistent with Their Imaging Work-up (ENDOBEST)

Impact of Ziwig Endotest® on the Decision and Management of Patients with Chronic Disabling Pelvic Pain Strongly Suggestive of Endometriosis and Presenting with a Negative or Uncertain Baseline Imaging Workup

Sponsor: Monitoring Force Group

Conditions Endometriosis
Interventions Ziwig Endotest®
Updated 2 times since 2025 Last updated: Jan 29, 2025 Started: Feb 1, 2025 Primary completion: Sep 1, 2026 Completion: Sep 1, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Endometriosis and is currently actively recruiting participants. Monitoring Force Group leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Feb 2025 – ~Mar 2025 · 28 days · monthly snapshot~Mar 2025 – present · 16 months · monthly snapshotNot Yet Recruiting

Change History

2 versions recorded
  1. Mar 2025 — Present [monthly]

    Not Yet Recruiting NA

  2. Feb 2025 — Mar 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Monitoring Force Group
  • ZIWIG
Data source: ZIWIG

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.